Catalyst Wire Dossier Catalyst Wire Dossier

Experimental Drug 3

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Experimental Drug 3, covering 2016-02-22 to 2016-02-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment Before [Phase 3]

See pricing